Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease
Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of tenofovir disoproxil fumarate in the treatment of Parkinson's disease. The changes of motor symptoms and the occurrence of adverse reactions in early Parkinson's disease patients who took tenofovir disoproxil fumarate and did not take Tenofovir disoproxil fumarate at different time points were compared.
Phase:
PHASE1
Details
Lead Sponsor:
The Fourth Affiliated Hospital of Zhejiang University School of Medicine